Quantib Brain 1.2

Quantib™ Brain 1.2 is an advanced MR image analysis software that performs automated, atlas-based segmentation for volumetric quantification of brain structures, including grey matter, white matter, CSF, and white matter hyperintensities. It supports both cross-sectional assessment and longitudinal tracking of these structures, providing clinicians with quantitative data to aid in the evaluation and monitoring of neurological conditions.

Quantib™ Brain 1.2 is a post-processing medical image analysis software designed for use with GE Advantage Workstation and Server platforms. Its primary function is the automatic labeling, visualization, and volumetric quantification of identifiable brain structures from magnetic resonance (MR) images, specifically utilizing 3D T1-weighted images for general brain structures and an additional T2-weighted FLAIR MR image for white matter hyperintensities (WMH) segmentation. The system employs an atlas-based segmentation methodology to differentiate and measure tissue segments such as grey matter, white matter, and cerebrospinal fluid, providing quantitative data on both absolute and relative volumes. While most segmentations are automatic, the software requires users to review and, if necessary, edit the automatically identified WMH candidates before their volumetric information is validated and used, ultimately aiming to provide complementary information to aid medical professionals in the evaluation, assessment, and quantitative reporting of MR brain images. This version 1.2 introduces enhancements including a modified user interface for WMH cross-sectional analysis, which now displays a sum of all hyperintensities rather than individual listings in the main table, though individual volumes remain accessible. A significant addition is the capability for longitudinal analysis of both brain volumetry and WMH segmentation, allowing comparison of multiple MRI studies from the same patient over time. This feature presents changes as mathematical differences and tracks appearing or disappearing WMH lesions using a newly implemented algorithm based on overlapping voxels. This specific algorithm for longitudinal WMH labeling (distinguishing consistent, new, and disappearing lesions) demonstrated that 99.6% of the automatically labeled WMH volume was identical to manual labeling in validation studies, while the core segmentation algorithms for cross-sectional analysis remain unchanged from the previous version.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How robust is the atlas-based segmentation to significant anatomical variations or the presence of large lesions that might distort typical brain morphology?; What is the minimum detectable change in brain volume or WMH load that the longitudinal analysis can reliably identify, considering inherent MR acquisition variability?; Could the WMH longitudinal labeling algorithm differentiate between true lesion change and subtle shifts due to image registration inaccuracies between time points?; How does the software handle MR images with varying quality or artifacts, and what is the impact on the accuracy of the segmentation and volumetric measurements?; Are there specific patient populations or neurological conditions for which Quantib™ Brain 1.2's automated segmentation and quantification have been most extensively validated?